Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

DANAHER (DHR)
Mes dernières consult.
Most popular
Delayed Quote. Delayed  - 10/19 08:18:34 pm
89.79 USD   +4.35%
04:21p S&P 500 MOVERS : Gpc, adbe
01:03p DANAHER : tops Street 3Q forecasts
12:08p DANAHER CORPORA : DHR) Files An 8-K Results of Operations and Financ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Danaher Corporation : Danaher CEO's 2011 Compensation Rises 27% From 2010

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/16/2012 | 07:42pm CEST

By Bob Tita

Of

Danaher Corp. (DHR) Chief Executive H. Lawrence Culp's total compensation in 2011 rose 27% from 2010 on a larger allocation of stock and options.

Culp's base salary, nonequity bonus, compensation for executive perks and awards of restricted stock shares and options totaled $21.7 million, compared with $17.03 million in 2010, according to a regulatory filing Friday with the U.S. Securities and Exchange Commission.

The cash portion of his pay rose to 6.3% to $5.87 million because of an 8% increase, worth $350,000, in his nonequity bonus based on the performance of the diversified industrial company. His base salary was unchanged from 2010 at $1.12 million.

Danaher's profit in 2011 rose 21% to from 2010 to $2.17 billion, or $3.11 a share. Revenue climbed 28% last year to $16.1 billion. The Washington, D.C.-based company's primary business segments include testing and measurement instruments; medical and dental equipment; and industrial technologies, such as bar-code identification equipment and factory process control systems.

Culp received stock and options worth $15 million on the day they were granted, a 37% increase from the stock and options granted to him in 2010. Culp was awarded 387,080 stock options with an exercise price of $49.59. He also received restricted stock shares worth $7.68 million on the day they were granted. Culp last year exercised options for 400,000 shares of Danaher stock that netted him $11.1 million when the shares were sold at Danaher's market price. Culp also received 28,000 shares of restricted stock worth $1.54 million when the shares vested.

Danaher awarded Culp $722,068 for executive perks, contributions to his 401(k) retirement account and other expenses. Of this amount, $17,464 went to his 401(k); $396,393 covered costs for his personal use of the company's aircraft; and $56,711 went toward expenses for tax-preparation, parking and tickets to entertainment events.

Culp, 49 years old, joined Danaher 22 years ago and became chief executive in 2001. In recent years, he has realigned Danaher's business portfolio by bailing out of highly cyclical companies with large bases of fixed assets in plants, machinery and materials and investing in technology companies where growth is largely driven by research and product-development activities. In 2011, Danaher acquired medical-test maker Beckman Coulter Inc. for $5.87 billion.

Danaher's stock Friday was recently trading up 0.16% at $53.04 a share.

-By Bob Tita, Dow Jones Newswires; 312-750-4129; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER
04:21p S&P 500 MOVERS : Gpc, adbe
01:03p DANAHER : tops Street 3Q forecasts
12:11p DANAHER : Investor Network: Danaher Corporation to Host Earnings Call
12:08p DANAHER CORPORATION (NYSE : DHR) Files An 8-K Results of Operations and Financia..
12:04p DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
12:03p DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
12:01p DANAHER : Reports Third Quarter 2017 Results
10/16DANAHER CORPORATION : quaterly earnings release
09/28 DANAHER : ex-dividend day
09/20 DANAHER : Schedules Third Quarter 2017 Earnings Conference Call
More news
News from SeekingAlpha
08:19a Danaher Corporation 2017 Q3 - Results - Earnings Call Slides
07:55a More on Danaher's Q3
06:02a Danaher Corporation beats by $0.05, beats on revenue
10/18 Notable earnings before Thursday?s open
09/26 Premarket analyst action - healthcare
Financials ($)
Sales 2017 18 078 M
EBIT 2017 3 307 M
Net income 2017 2 291 M
Debt 2017 9 387 M
Yield 2017 0,63%
P/E ratio 2017 24,86
P/E ratio 2018 22,61
EV / Sales 2017 3,83x
EV / Sales 2018 3,51x
Capitalization 59 778 M
Chart DANAHER
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Technical analysis trends DANAHER
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 91,8 $
Spread / Average Target 6,6%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER10.55%59 778
THERMO FISHER SCIENTIFIC INC.34.10%75 478
BOSTON SCIENTIFIC CORPORATION36.48%40 505
INTUITIVE SURGICAL67.64%39 496
ROYAL PHILIPS20.07%38 649
ILLUMINA60.59%30 082